Research programme: nitric oxide donors - Inotek PharmaceuticalsAlternative Names: Nitric oxide-releasing compounds - Inotek Pharmaceuticals
Latest Information Update: 08 Aug 2007
At a glance
- Originator Inotek Pharmaceuticals
- Mechanism of Action Nitric oxide donors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diabetic foot ulcer; Female sexual dysfunction
Most Recent Events
- 08 Aug 2007 Discontinued - Preclinical for Female sexual dysfunction in USA (unspecified route)
- 08 Aug 2007 Discontinued - Preclinical for Diabetic foot ulcer in USA (Topical)
- 10 Nov 2003 Preclinical trials in Female sexual dysfunction in USA (unspecified route)